Varun Khurana, Ph.D. - Publications

Affiliations: 
2014 Pharmaceutical Science University of Missouri - Kansas City, USA 
Area:
Pharmacy

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Mandal A, Cholkar K, Khurana V, Shah A, Agrahari V, Bisht R, Pal D, Mitra AK. Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery. Molecular Pharmaceutics. PMID 28471177 DOI: 10.1021/Acs.Molpharmaceut.7B00128  0.573
2016 Mandal A, Agrahari V, Khurana V, Pal D, Mitra AK. Transporter effects on cell permeability in drug delivery. Expert Opinion On Drug Delivery. PMID 27449574 DOI: 10.1080/17425247.2016.1214565  0.558
2015 Mitra AK, Agrahari V, Mandal A, Cholkar K, Natarajan C, Shah S, Joseph M, Trinh HM, Vaishya R, Yang X, Hao Y, Khurana V, Pal D. Novel delivery approaches for cancer therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26456750 DOI: 10.1016/J.Jconrel.2015.09.067  0.54
2015 Vaishya R, Khurana V, Patel S, Mitra AK. Long-term delivery of protein therapeutics. Expert Opinion On Drug Delivery. 12: 415-40. PMID 25251334 DOI: 10.1517/17425247.2015.961420  0.478
2015 Khurana V, Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells. Current Eye Research. 40: 457-69. PMID 25014399 DOI: 10.3109/02713683.2014.935443  0.706
2014 Khurana V, Kwatra D, Pal D, Mitra AK. Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells. International Journal of Pharmaceutics. 474: 14-24. PMID 25102111 DOI: 10.1016/J.Ijpharm.2014.07.056  0.722
2014 Vaishya RD, Khurana V, Patel S, Mitra AK. Controlled ocular drug delivery with nanomicelles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 422-37. PMID 24888969 DOI: 10.1002/Wnan.1272  0.477
2014 Khurana V, Minocha M, Pal D, Mitra AK. Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions. 29: 249-59. PMID 24807167 DOI: 10.1515/dmdi-2014-0014  0.71
2014 Khurana V, Minocha M, Pal D, Mitra AK. Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions. 29: 179-90. PMID 24643910 DOI: 10.1515/Dmdi-2013-0062  0.707
2014 Kwatra D, Vadlapudi AD, Vadlapatla RK, Khurana V, Pal D, Mitra AK. Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters. Drug Metabolism and Drug Interactions. 29: 101-10. PMID 24399676 DOI: 10.1515/Dmdi-2013-0056  0.687
2013 Gaudana R, Gokulgandhi M, Khurana V, Kwatra D, Mitra AK. Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme. Pharmaceutical Development and Technology. 18: 752-9. PMID 23137392 DOI: 10.3109/10837450.2012.737806  0.651
2012 Minocha M, Khurana V, Mitra AK. Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS). Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 901: 85-92. PMID 22749591 DOI: 10.1016/J.Jchromb.2012.06.004  0.687
2012 Minocha M, Khurana V, Qin B, Pal D, Mitra AK. Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib. International Journal of Pharmaceutics. 436: 127-34. PMID 22688250 DOI: 10.1016/J.Ijpharm.2012.05.038  0.731
2012 Minocha M, Khurana V, Qin B, Pal D, Mitra AK. Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors. International Journal of Pharmaceutics. 434: 306-14. PMID 22633931 DOI: 10.1016/J.Ijpharm.2012.05.028  0.733
2011 Gaudana R, Khurana V, Parenky A, Mitra AK. Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles. Journal of Drug Delivery. 2011: 458128. PMID 21603214 DOI: 10.1155/2011/458128  0.739
2011 Luo S, Wang Z, Patel M, Khurana V, Zhu X, Pal D, Mitra AK. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir. International Journal of Pharmaceutics. 414: 77-85. PMID 21571053 DOI: 10.1016/J.Ijpharm.2011.05.001  0.704
Show low-probability matches.